P19-06. The first hypervariable loop and HIV-1 neutralizing antibodies elicited by gp140 env immunogens

P19-06. The first hypervariable loop and HIV-1 neutralizing antibodies elicited by gp140 env immunogens

Bibliographic Details
Main Authors:	Stamatatos L, Ching LK
Format:	Article
Language:	English
Published:	BMC 2009-10-01
Series:	Retrovirology

Similar Items

Repeated Vaccination of Cows with HIV Env gp140 during Subsequent Pregnancies Elicits and Sustains an Enduring Strong Env-Binding and Neutralising Antibody Response.
by: Behnaz Heydarchi, et al.
Published: (2016-01-01)

Targeting HIV-1 Env gp140 to LOX-1 Elicits Immune Responses in Rhesus Macaques.
by: Gerard Zurawski, et al.
Published: (2016-01-01)

Antibody elicited by HIV-1 immunogen vaccination in macaques displaces Env fusion peptide and destroys a neutralizing epitope
by: Morgan E. Abernathy, et al.
Published: (2021-10-01)

Elicitation of Neutralising Antibodies Using Patient-Derived gp140 Immunogens from a Long-Term Non-Progressor
by: Bowles, E, et al.
Published: (2011)

Comparison of neutralizing antibody responses elicited from highly diverse polyvalent heterotrimeric HIV-1 gp140 cocktail immunogens versus a monovalent counterpart in rhesus macaques
by: Bowles, EJ, et al.
Published: (2014)

Comparison of neutralizing antibody responses elicited from highly diverse polyvalent heterotrimeric HIV-1 gp140 cocktail immunogens versus a monovalent counterpart in rhesus macaques.
by: Emma J Bowles, et al.
Published: (2014-01-01)

Neutralizing antibodies elicited in rabbits by patient-derived Env trimer immunization
by: Heyndrickx L, et al.
Published: (2012-09-01)

A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies.
by: Rogier W Sanders, et al.
Published: (2013-09-01)

Specifically modified Env immunogens activate B-cell precursors of broadly neutralizing HIV-1 antibodies in transgenic mice
by: Andrew T. McGuire, et al.
Published: (2016-02-01)

Differences in Allelic Frequency and CDRH3 Region Limit the Engagement of HIV Env Immunogens by Putative VRC01 Neutralizing Antibody Precursors
by: Christina Yacoob, et al.
Published: (2016-11-01)

Evolution of cross-neutralizing antibody specificities to the CD4-BS and the carbohydrate cloak of the HIV Env in an HIV-1-infected subject.
by: Iliyana Mikell, et al.
Published: (2012-01-01)

Antibody to gp41 MPER alters functional properties of HIV-1 Env without complete neutralization.
by: Arthur S Kim, et al.
Published: (2014-07-01)

P14-06. Phase 1 safety and immunogenicity randomised controlled trial of a vaginal gp140 vaccine
by: Giemza E, et al.
Published: (2009-10-01)

Soluble HIV-1 envelope immunogens derived from an elite neutralizer elicit cross-reactive V1V2 antibodies and low potency neutralizing antibodies.
by: Sara Carbonetti, et al.
Published: (2014-01-01)

Characterization and Immunogenicity of HIV Envelope gp140 Zera® Tagged Antigens
by: Phindile Ximba, et al.
Published: (2020-04-01)

Rapid development of cross-clade neutralizing antibody responses after clade B gp120/gp140 protein priming and clade c gp140 protein boosting
by: Spearman P, et al.
Published: (2012-09-01)

Enhanced immunogenicity of HIV-1 envelope gp140 proteins fused to APRIL.
by: Gözde Isik, et al.
Published: (2014-01-01)

Engineered gp120 immunogens that elicit VRC01-like antibodies by vaccination
by: Mata-Fink, Jordi, et al.
Published: (2013)

Production and Immunogenicity of Soluble Plant-Produced HIV-1 Subtype C Envelope gp140 Immunogens
by: Emmanuel Margolin, et al.
Published: (2019-10-01)

Eliciting broadly neutralizing antibodies against HIV-1 that target gp41 MPER
by: Han D, et al.
Published: (2012-09-01)

Comparative immunogenicity of HIV-1 gp160, gp140 and gp120 expressed by live attenuated newcastle disease virus vector.
by: Sunil K Khattar, et al.
Published: (2013-01-01)

Cross-reactive Anti-gp41 HIV-1 Neutralizing Human Monoclonal Antibodies Selected by Competitive Panning Against gp140 – an Update
by: Sidorov Igor, et al.
Published: (2005-12-01)

P05-12. A computationally designed immunogen elicits potent anti-V3 neutralizing antibodies
by: Stamatatos L, et al.
Published: (2009-10-01)

Sequential immunization of macaques elicits heterologous neutralizing antibodies targeting the V3-glycan patch of HIV-1 Env
by: Escolano, Amelia, et al.
Published: (2023)

P19-42. Engineering, expression and antigenic and immunogenic characterization of novel soluble clade A/B heterotrimeric gp140-envelope glycoproteins
by: Stamatatos L, et al.
Published: (2009-10-01)

Correction: Comparative Immunogenicity of HIV-1 gp160, gp140 and gp120 Expressed by Live Attenuated Newcastle Disease Virus Vector
Published: (2014-01-01)

Correction: Comparative Immunogenicity of HIV-1 gp160, gp140 and gp120 Expressed by Live Attenuated Newcastle Disease Virus Vector.
by: Sunil K. Khattar, et al.
Published: (2014-01-01)

Retraction: Comparative immunogenicity of HIV-1 gp160, gp140 and gp120 expressed by live attenuated newcastle disease virus vector.
by: PLOS ONE Editors
Published: (2020-01-01)

Engineering of HIV gp120 by yeast surface display for neutralizing antibody characterization and immunogen design
by: Mata-Fink, Jordi
Published: (2013)

Elicitation of potent serum neutralizing antibody responses in rabbits by immunization with an HIV-1 clade C trimeric Env derived from an Indian elite neutralizer.
by: Rajesh Kumar, et al.
Published: (2021-04-01)

Polyclonal antibody responses to HIV Env immunogens resolved using cryoEM
by: Aleksandar Antanasijevic, et al.
Published: (2021-08-01)

P19-23. Putative prefusion mechanism of HIV-1 Env revealed by ligand-induced quaternary alterations in o-gp140 trimers
by: Barnett S, et al.
Published: (2009-10-01)

Fusion of the molecular adjuvant C3d to cleavage-independent native-like HIV-1 Env trimers improves the elicited antibody response
by: Shridhar Bale, et al.
Published: (2023-05-01)

Differential Antibody Responses to Conserved HIV-1 Neutralizing Epitopes in the Context of Multivalent Scaffolds and Native-Like gp140 Trimers
by: Charles D. Morris, et al.
Published: (2017-03-01)

Immunogenicity of HIV-1 gp140 - microbicide mixtures in mice using a vaginal delivery model
by: Wegmann, F, et al.
Published: (2007)

Rationally designed carbohydrate-occluded epitopes elicit HIV-1 Env-specific antibodies
by: Cheng Zhu, et al.
Published: (2019-02-01)

Immune focusing and enhanced neutralization induced by HIV-1 gp140 chemical cross-linking.
by: Schiffner, T, et al.
Published: (2013)

Analysis of two cooperating antibodies unveils immune pressure imposed on HIV Env to elicit a V3-glycan supersite broadly neutralizing antibody lineage
by: Maxwell T. Finkelstein, et al.
Published: (2022-09-01)

P19-17. Construction of HIV-1 AE subtype gp140 DNA vaccine and immunogenicity evaluation
by: Wan Y, et al.
Published: (2009-10-01)

Hyperglycosylated resurfaced stabilized GP120 core as an immunogen elicits antibodies targeted at the CD4-binding site
by: Dai K, et al.
Published: (2012-09-01)